T (B+F)/F B/F 0.8 1.8 3.4 ‘late’ or ‘early’ image? whose brain is this? why a CT scan first? why increasing contrast w/ time? why increasing noise w/time?

Slides:



Advertisements
Similar presentations
LAKSHMAN KARALLIEDDE OCTOBER 2011
Advertisements

DR. SHABANA ALI (Asso. Prof.) Kd- Dissociation constant.
1 Low-Dose Dual-Energy CT for PET Attenuation Correction with Statistical Sinogram Restoration Joonki Noh, Jeffrey A. Fessler EECS Department, The University.
Copyright © 2009 Pearson Education, Inc. Chapter 29 Multiple Regression.
The General Linear Model Or, What the Hell’s Going on During Estimation?
IPlant G-to-P test case for visualization: Model parameter estimation for QTL analysis Prepared by Jeff White out of Feb working group meeting in.
A polylogarithmic approximation of the minimum bisection Robert Krauthgamer The Hebrew University Joint work with Uri Feige.
Rate Laws Example: Determine the rate law for the following reaction given the data below. H 2 O 2 (aq) + 3 I - (aq) + 2H + (aq)  I 3 - (aq) + H 2 O (l)
Mirror Results Presentation AKA Let’s PartY, PartX.
Concepts for discussion 1.synopses – don’t overdo it 2.how comfortable were you with Wagner paper, Mintun, Farde? 3.non-specific vs specific binding 4.how.
ANALYSIS OF PET STUDIES Turku PET Centre V Oikonen PET Raw Data (sinogram) Results Parametric Sinogram PET Image Parametric Image Regional TACs.
Imaging Drugs in the Brain ENAS 880 / NSCI 523 Fall 2010 Morris/Cosgrove kelly
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
What are some of the issues in choosing bolus vs bolus+infusion? Which one predicts equilibrium coefficients? Which one achieves equilibrium? Which one.
Imaging Drugs in the Brain ENAS 880 / NSCI 523 Fall 2010 Morris/Cosgrove kelly
Goal:. design 11C-FLB457 perospirone Why? In the Arakawa paper, where does the baseline (aka ‘control’) data come from? From Vernaleken et al…
Week 4 - Biopharmaceutics and Pharmacokinetics
Introduction to Adaptive Digital Filters Algorithms
Receptor Occupancy estimation by using Bayesian varying coefficient model Young researcher day 21 September 2007 Astrid Jullion Philippe Lambert François.
Background Objectives Data Simulation in human Conclusion -F14512, a polyamine-vectorized anti-cancer drug which combines an epipodophyllotoxin core targeting.
Jeff J. Orchard, M. Stella Atkins School of Computing Science, Simon Fraser University Freire et al. (1) pointed out that least squares based registration.
M. Ronen, G. Chandy, T. Meyer & J.E. Ferrell. Curve Feature Extraction basal storage Sustained (delta/ratio) Max amplitude (delta / ratio) Max slope Time.
Rates. Unit Rate A rate is a comparison of two quantities with different units For instance speed is the rate of displacement over time or the rate at.
HuBio 543 September 6, 2007 Frank F. Vincenzi
MIPR Lecture 4 Copyright Oleh Tretiak, Medical Imaging and Pattern Recognition Lecture 4 Visibility and Noise, Certainty in Medical Decisions Oleh.
Biological Explanations for Schizophrenia
Validation of Methods of Estimating % Body Fat
Supplementary Figure 1A. Striatal correlation pattern of D2BP with BMI corrected for age as represented by t-maps. A Negative Correlation Positive Correlation.
Linearized models in PET Vesa Oikonen Turku PET Centre – Modelling workshop Modelling workshop
Density Graph Rules of Construction. Density Graphing Rules  First, look at all your values for mass and volume.  Next, decide on a scale that best.
Obsessive- Csompulsive Disorder ( 25/9/2013 ) Elham aljammas.
Comparison of methodologies for the assessment of dopamine receptor binding in subregions of the striatum Functional Neuroimaging Lab School of Psychology.
GENERATION OF PARAMETRIC IMAGES PROSPECTS PROBLEMS Vesa Oikonen Turku PET Centre
11 Motivation  Nicotine causes DA release in the striatum, part of the mesolimbic DA pathway which mediates reinforcing behaviors (Martin-Soelch et al,
Beam-Beam simulation and experiments in RHIC By Vahid Ranjbar and Tanaji Sen FNAL.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Modafinil on Dopamine and Dopamine Transporters.
Validation of Methods of Estimating % Body Fat. How do you validate these techniques? There can be no direct validation – Measure subjects with technique.
Obsessive-Csompulsive Disorder (25/9/2013)
Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates  Dah-Ren Hwang, Essa Hu, Jennifer R. Allen,
Evaluating Classifiers
Validation of Methods of Estimating % Body Fat
Validation of Methods of Estimating % Body Fat
Validation of Methods of Estimating % Body Fat
Figure 1. (A) Mean MPPF BPND concentration at basal state in ASD patients group (N = 18), color bar = MPPF BPND value. The color bar represents.
OK. What if we don’t care about the kinetics of a particular tracee molecule (e.g., glucose). Rather, we care about counting up the number of one type.
Driven SHM k m Last time added damping. Got this kind of solution that oscillates due to initial conditions, but then decays. This is an important concept.
Validation of Methods of Estimating % Body Fat
Multidisciplinary Engineering Senior Design Project P06441 See Through Fog Imaging Preliminary Design Review 05/19/06 Project Sponsor: Dr. Rao Team Members:
Species Comparison of the Binding Properties for Three D2/3-DAR
Tissue response compared to receptor occupation
Masahiro Ueda, Tatsuo Shibata  Biophysical Journal 
Validation of Methods of Estimating % Body Fat
Fiona E. Müllner, Sheyum Syed, Paul R. Selvin, Fred J. Sigworth 
Model Part – Yiming Weng
Signal and Noise in fMRI
DOSE SPACING IN EARLY DOSE RESPONSE CLINICAL TRIAL DESIGNS
Spatiochromatic Properties of Natural Images and Human Vision
Consider Covariance Analysis Example 6.9, Spring-Mass
Receptive substances proposed 1909 by Langley (nicotine)
Large Currents Generate Cardiac Ca2+ Sparks
Franco Pestilli, Marisa Carrasco, David J. Heeger, Justin L. Gardner 
Driven SHM k m Last time added damping. Got this kind of solution that oscillates due to initial conditions, but then decays. This is an important concept.
Thomas E. Brothers, MD, Jacob G. Robison, MD, Bruce M
Franco Pestilli, Marisa Carrasco, David J. Heeger, Justin L. Gardner 
Rheological Analysis and Measurement of Neutrophil Indentation
Plot of BOUND against FREE ligand
M. Maravall, Z.F. Mainen, B.L. Sabatini, K. Svoboda 
Drug- Receptor Interaction
Reliability in Measurements
The effect of a change in the expression level of the receptor and the binding affinity on the subcutaneous bioavailability of mAbs. The effect of a change.
Presentation transcript:

t (B+F)/F B/F ‘late’ or ‘early’ image? whose brain is this? why a CT scan first? why increasing contrast w/ time? why increasing noise w/time? what is the point of excess cold spiperone? what do we learn from it re the caudate? can we compare these numbers across scans? why divide by cerebellum value? could we do this exp’t in a human?

where do error bars come from? (if so) is the Y axis correct? where does “specific putamen” come from – special brain area known only in Sweden? what is plotted? (B vs F) – how did they get these values? how did they get 5 data points what is the slope near origin? what is the assymptotic value for Y axis? where does “expected spec binding” come from? Is this a safe comparison? what factors are ignored? understand this? got equilibrium?

raclo in cereb (assume = free) --> plug into Bmax*Free/[Kd + Free] using Bmax and Kd from Healthy controls --> predicts B at equilib for schizo patients. Compare to actual B measured for patients (via [striat-cereb] per injected dose – I hope) first ‘drug occupancy’ study with PET? receptor occup =  B/B (fractional change in binding due to presence of bound drug) = (B predicted – B actual )/B predicted claim: uniformity of occupancy of D2 by different drugs suggests that occupancy level is related to efficacy.

PFB typically written as… what’s all this about? what is  ? conservation of mass under what condition? what is the blue? what is the fraction of P that is blue – according to Mintun? according to us? Mintun: can’t estimate Bmax and rate constants from high spec act expm’t

parameter estimation – what is it? why is it iterative? simulations? what are they good for? what are they used for here? sensitivity analysis – huh? k on *B max = B max k off K D BP is an equilibrium ratio (has not units of time or rates) but we can get it from a TRANSIENT experiment.

anything tricky about using an in vitro sample for anatomy? what’s the difference between expt 1 and expt 2 in same baboon? why didn’t they estimate BP in 2 nd study?

terms for next week: Sept 21 displacement release endogenous simulation what is Logan proving by her simulations? where they get their parameter vals what things might be causing DA release in Koepp expt? what might have been a better control condition(s)? what do (+) changes in binding potential (Fig 2) mean? what is the ‘proof’ that DA release is being measured? what is being optimized in Morris paper? where do they get their parameter vals?